title: Long-lasting antinociceptive effect of DAMGO chloromethyl ketone in rats.
abstract: Previously, the opioid peptide Tyr-D-Ala-Gly-(NMe)Phe-CH2Cl (DAMCK) has been shown to bind irreversibly to mu opioid receptors in vitro. In the present work, the antinociceptive effect of DAMCK has been evaluated. Rats treated systemically with DAMCK (1-100 pg/kg) displayed a dose-dependent increase in tail-flick analgesia that peaked by 15 min, then stayed about the same until 60 min, followed by some decrease over time. Higher doses of DAMCK (10 ng/kg-100 microg/kg) produced a near-maximal antinociceptive effect that remained stable for 4 h. Significant antinociception was still detected 8 h, but not 24 h postinjection. In comparison, the parent peptide DAMGO (Tyr-D-Ala-Gly-(NMe)Phe-Gly-ol) reached maximal effect by about 30 min, followed by a rapid cessation of its antinociceptive response. Naloxone administered before DAMCK antagonized the antinociceptive response of DAMCK, indicating that it was mediated via opioid receptors. Naloxone administered 45 min after DAMCK attenuated the tail-flick response to some extent, but a substantial part (40-60% depending on the peptide concentration and evaluation time) remained unaffected. Central administration of DAMCK also elicited time- and concentration-dependent, profound, opioid receptor mediated, apparently irreversible antinociception.
authors.affiliation: Department of Pathophysiology, Albert Szent-Györgyi Medical University, Szeged, Hungary. szabog@patph.szote.u-szeged.hu
authors.forename: G
authors.initials: G
authors.lastname: Szabó
authors.forename: M
authors.initials: M
authors.lastname: Mácsai
authors.forename: E G
authors.initials: EG
authors.lastname: Kicsi
authors.forename: A
authors.initials: A
authors.lastname: Magyar
authors.forename: J
authors.initials: J
authors.lastname: Farkas
authors.forename: G
authors.initials: G
authors.lastname: Tóth
authors.forename: M
authors.initials: M
authors.lastname: Szucs
mesh_terms: D000590:Amino Acid Chloromethyl Ketones / Q000008:administration & dosage / Q000494:pharmacology*; D000700:Analgesics / Q000008:administration & dosage / Q000494:pharmacology*; D000818:Animals; D020875:Enkephalin, Ala(2)-MePhe(4)-Gly(5)- / Q000494:pharmacology; D007275:Injections, Intravenous; D007276:Injections, Intraventricular; D008297:Male; D051381:Rats; D017208:Rats, Wistar
chemical_list: D000590:Amino Acid Chloromethyl Ketones; D000700:Analgesics; D020875:Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; C052900:tyrosyl-alanyl-glycyl-N(alpha)-methylphenylalanine chloromethyl ketone